BMS-345541 Hydrochloride: Selective IKK Inhibitor for NF-κB Pathway Research

Executive Summary: BMS-345541 hydrochloride is a small molecule inhibitor that targets IKK-1 and IKK-2 with high selectivity, demonstrating IC50 values of 4 μM and 0.3 μM, respectively (APExBIO). It blocks NF-κB-dependent transcription by preventing IκBα phosphorylation, leading to reduced production of pro-inflammatory cytokines (Zhao et al., 2025). The compound is water-soluble at ≥60 mg/mL, orally bioavailable in vivo, and induces apoptosis as well as G2/M cell cycle arrest in T-ALL cell lines. These combined features position BMS-345541 hydrochloride as an optimal tool for dissecting inflammatory signaling and overcoming chemotherapeutic resistance in leukemia research.

Biological Rationale

The NF-κB signaling pathway is a central regulator of inflammation, immunity, and cell survival. Aberrant activation of NF-κB is implicated in chronic inflammatory diseases and various cancers, including T-cell acute lymphoblastic leukemia (T-ALL). The pathway is activated by phosphorylation of IκBα by IκB kinase (IKK) complex subunits IKK-1 (IKKα) and IKK-2 (IKKβ), leading to nuclear translocation of NF-κB and transcriptional activation of genes encoding cytokines such as TNFα, IL-1β, IL-6, and IL-8 (Zhao et al., 2025). Selective inhibition of the IKK/NF-κB axis is therefore a validated approach to modulate inflammation and tumor progression.

Mechanism of Action of BMS-345541 hydrochloride

BMS-345541 hydrochloride specifically binds to an allosteric site of IKK-1 and IKK-2, blocking substrate access and enzyme activity. This inhibition prevents phosphorylation and subsequent degradation of IκBα, retaining NF-κB in the cytoplasm and suppressing its transcriptional program. The selectivity profile of BMS-345541 ensures minimal off-target inhibition of other serine/threonine and tyrosine kinases, preserving signaling specificity (APExBIO). In cellular assays, BMS-345541 suppresses stimulus-induced IκBα phosphorylation and downstream cytokine gene expression.

Evidence & Benchmarks

• BMS-345541 hydrochloride inhibits IKK-2 with an IC50 of 0.3 μM and IKK-1 with an IC50 of 4 μM in vitro kinase assays (APExBIO).
• It suppresses TNFα, IL-1β, IL-6, and IL-8 mRNA expression in stimulated immune cell cultures (Zhao et al., 2025).
• In vivo, oral administration of BMS-345541 achieves 100% bioavailability and significantly reduces serum TNFα in mouse models of inflammation (APExBIO).
• The compound induces apoptosis and G2/M cell cycle arrest in T-ALL leukemia cell lines, demonstrating potential for overcoming chemoresistance (Related Article).
• BMS-345541 hydrochloride displays robust solubility in water (≥60 mg/mL), but is insoluble in ethanol and DMSO without warming/sonication (APExBIO).

This article expands upon the foundational overview in BMS-345541 Hydrochloride: Selective IKK Inhibitor for Adv... by providing benchmark data and in vivo efficacy details not previously discussed.

Applications, Limits & Misconceptions

BMS-345541 hydrochloride is primarily applied in the following research contexts:

• Dissection of the IKK/NF-κB signaling pathway in cell-based and animal models.
• Evaluation of anti-inflammatory mechanisms via suppression of pro-inflammatory cytokine production.
• Induction of apoptosis and cell cycle arrest in leukemia and other cancer cell lines.
• Preclinical studies of chemotherapeutic resistance modulation in T-ALL models.

Common Pitfalls or Misconceptions

• Not a pan-kinase inhibitor: BMS-345541 is highly selective for IKK-1 and IKK-2; it does not inhibit most other serine/threonine or tyrosine kinases at working concentrations.
• Solubility limitations: The compound is insoluble in ethanol and DMSO at room temperature; warming and sonication are required for DMSO stock preparation.
• Not suitable for chronic in vivo studies: Long-term storage of solutions is not recommended; stability may be compromised beyond recommended conditions.
• No direct antibacterial effect: While anti-inflammatory, BMS-345541 does not exhibit antimicrobial activity, unlike drug-eluting stents with antibiotics (Zhao et al., 2025).
• Does not block all NF-κB-independent cytokine production: Cytokines induced via non-canonical pathways may not be fully suppressed.

This clarification extends the troubleshooting and workflow guidance presented in BMS-345541 Hydrochloride: Selective IKK Inhibitor for Inf..., highlighting boundaries and optimal assay conditions.

Workflow Integration & Parameters

BMS-345541 hydrochloride is supplied by APExBIO (SKU: A3248). For in vitro studies, it is typically prepared as a 10–100 mM stock in DMSO with gentle warming and sonication. Working concentrations range from 0.04–100 μM, depending on cell type, stimulus, and endpoint assay. The compound is water-soluble at ≥60 mg/mL, permitting direct aqueous application for certain protocols. For in vivo applications, oral administration is feasible due to complete bioavailability in mice. Storage at -20°C is required; avoid repeated freeze-thaw cycles and prolonged solution storage. Researchers should consult advanced workflow optimization tips as detailed in this comprehensive guide, which this article updates with the latest in vivo and cytokine inhibition results.

Conclusion & Outlook

BMS-345541 hydrochloride remains a gold-standard tool for precise, selective inhibition of the IKK/NF-κB pathway in inflammation and cancer research. Its reproducible performance, water solubility, and proven efficacy in suppressing pro-inflammatory cytokines and inducing apoptosis in T-ALL models make it indispensable for mechanistic and translational studies. Future research will further define its role in combination therapy and resistance management in hematologic malignancies. For full specifications and ordering information, consult the product page at APExBIO.